Effects of active immunization against clenbuterol on the growth-promoting effect of clenbuterol in rats.
We examined the effect of active immunization against clenbuterol on the growth-promoting effect of clenbuterol in rats in two experiments. Six-week-old female Sprague-Dawley rats were immunized against clenbuterol conjugated to histone by diazotization and then received clenbuterol approximately 4 wk after the initiation of immunization. Antibody titers were determined using indirect ELISA with diazotized clenbuterol-BSA conjugate as an antigen in coating the microwells. Antibody titer increased during booster injections. No significant difference in titer value was observed between two doses of immunogen (.1 vs .5 mg). Competitive ELISA showed that terbutaline cross-reacted with anti-clenbuterol antibodies, and the cross-reactivity was 12%. Alprenolol, propranolol, phentolamine, epinephrine, norepinephrine, and L644,969 showed no affinity for anti-clenbuterol antibodies. The rats immunized against clenbuterol-histone conjugate had 11% lower body weight gain during the 23-d immunization period than the rats immunized against histone only. When clenbuterol was administered after the immunization, no significant difference in growth rate was observed between the rats immunized against clenbuterol-histone conjugate and rats immunized against histone only. No significant difference in muscle weight was observed between the two groups at the termination of the experiment. Results indicate that active immunization against clenbuterol before clenbuterol administration did not modify the growth-promoting effects of clenbuterol in rats.
Kim
Y H
YH
Department of Animal Sciences, University of Hawaii at Manoa, Honolulu 96822, USA.
Kim
Y S
YS
D000318:Adrenergic beta-Agonists / Q000737:chemistry / Q000276:immunology* / Q000494:pharmacology*; D000526:Alprenolol / Q000378:metabolism; D000818:Animals; D000906:Antibodies / Q000097:blood / Q000276:immunology / Q000378:metabolism; D002976:Clenbuterol / Q000737:chemistry / Q000276:immunology* / Q000494:pharmacology*; D003429:Cross Reactions; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods / Q000662:veterinary; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D006128:Growth / Q000187:drug effects* / Q000502:physiology; D006133:Growth Substances / Q000737:chemistry / Q000276:immunology* / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D010646:Phentolamine / Q000378:metabolism; D011433:Propranolol / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D014611:Vaccination / Q000662:veterinary*
D000318:Adrenergic beta-Agonists; D000906:Antibodies; D006133:Growth Substances; D000526:Alprenolol; D011433:Propranolol; D009638:Norepinephrine; D002976:Clenbuterol; D004837:Epinephrine; D010646:Phentolamine